A first-in-human proof-of-concept study with NVDX3, an osteogenic implant of human allogenic origin, in the treatment of distal radius fractures in adults.

Status

Completed

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508321-27-00

Enrollment

Registered

2024-01-18

Start date

2023-08-08

Completion date

2024-12-19

Last updated

2025-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distal radius fractures

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Luxembourg

None listed

Source: EU CTIS · Data processed: Feb 4, 2026